Stock ULTI ULTIMOVACS ASA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ultimovacs ASA

Equities

ULTI

NO0010851603

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-06-21 EDT 		5-day change 1st Jan Change
7.85 NOK +0.64% Intraday chart for Ultimovacs ASA -9.04% -93.61%
06-11 Ultimovacs Asa Provides Update from Phase I Study in Malignant Melanoma CI
05-07 Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ultimovacs provides update from Phase I study in malignant melanoma: Continued strong overall survival in patients treated with UV1 cancer vaccine and pembrolizumab
GL
Ultimovacs : INITIUM Poster presentation at ASCO, June 1, 2024
PU
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
AQ
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Ultimovacs : presentation per May 7, 2024
PU
Ultimovacs Q1 2024 - Survival mode
AQ
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
GL
Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation
GL
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
GL
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
AQ
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
GL
Ultimovacs - Invitation to Business Update on April 17, 2024
AQ
Ultimovacs – Invitation to Business Update on April 17, 2024
GL
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024  
GL
Ultimovacs : TENDU trial Poster presentation at AACR 2024
PU
Ultimovacs : Company Presentation as per March 23, 2024
PU
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
GL
Ultimovacs ASA: Mandatory notification of trade by primary insider
GL
Ultimovacs ASA: Mandatory notification of trade by primary insider
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ULTI Stock
  4. News Ultimovacs ASA
  5. Press Releases